AU Patent

AU2022397292A1 — Varicella-zoster virus immunogen compositions and their uses

Assigned to Flagship Pioneering Innovations VI Inc · Expires 2024-05-30 · 2y expired

What this patent protects

This disclosure provides compositions, pharmaceutical preparations, and methods relating to circular polyribonucleotides encoding the expression of Varicella-Zoster Virus immunogens.

USPTO Abstract

This disclosure provides compositions, pharmaceutical preparations, and methods relating to circular polyribonucleotides encoding the expression of Varicella-Zoster Virus immunogens.

Drugs covered by this patent

Patent Metadata

Patent number
AU2022397292A1
Jurisdiction
AU
Classification
—
Expires
2024-05-30
Drug substance claim
No
Drug product claim
No
Assignee
Flagship Pioneering Innovations VI Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.